We found 173 records for "Licensing / acquisition"

Articles

Does the drug industry need a new pricing model?

12th January 2015

 Does the drug industry need a new pricing model?Articles

Various approaches have been taken to try to balance the rising costs of new medicines with tightening healthcare budgets, but few have proved effective long-term. Advances in drug development are...

Read more

20 People who shaped healthcare in 2014 (Part 4)

2nd January 2015

 20 People who shaped healthcare in 2014 (Part 4)Articles

In the final instalment of our review of 2014, Andrew McConaghie looks at how patient advocates in rare diseases and 'activist investors' have shaped healthcare – and will continue to...

Read more

Selling science to potential investors and partners

12th September 2014

 Selling science to potential investors and partnersArticles

Start-ups and biotechs often need the support of outside investors to take their innovations to the next level. So what are the considerations when preparing a presentation for these important...

Read more

Adaptive Licensing: Could patients be the answer to the data problem?

4th August 2014

 Adaptive Licensing: Could patients be the answer to the data problem?Articles

Patients could play a key role in generating the data required to make Europe's Adaptive Licensing a success.The timing of patient access to new medicines has always been one of...

Read more

News

Is a deal to create 'PfizerKline' in the offing?

22nd May 2015

 Is a deal to create 'PfizerKline' in the offing?News

The rumour mill has been grinding away furiously in the last few days, focusing mainly on a possible bid for GlaxoSmithKline (GSK) by Pfizer.The speculation about a deal to create...

Read more

Boehringer licenses liver disease candidate

19th May 2015

 Boehringer licenses liver disease candidateNews

Boehringer Ingelheim (BI) has licensed a drug for non-alcoholic fatty liver diseases from Australia's Pharmaxis, adding another candidate to its portfolio of drugs for fibrotic diseases.The German company is paying...

Read more

Mylan and Teva trade blows as Perrigo backs away

30th April 2015

 Mylan and Teva trade blows as Perrigo backs awayNews

Teva and Mylan are continuing to press their takeover bids in an increasingly hostile M&A chain, while Perrigo remains staunch in its defence.Ireland-based Perrigo has just rejected Mylan's third offer...

Read more

AZ's Celgene tie-up 'will boost immuno-oncology business'

27th April 2015

 AZ's Celgene tie-up 'will boost immuno-oncology business'News

AstraZeneca (AZ) has forged an alliance with Celgene to accelerate the development of its checkpoint inhibitor MEDI4736 in blood cancers.The deal is one of two designed to bolster the potential...

Read more

White Papers

All change for pharma and biotech partnerships

30th September 2013

 All change for pharma and biotech partnershipsWhite Papers

The pharma industry is always evolving, and in the past decade, there has been an increasing reliance on partnering to strengthen R&D. In this original white paper, Phenestra shares its...

Read more

Audio & Video

Live webinar/debate - Feb 4th - COPD, connecting real world needs to patient centric solutions

    COPD is a widespread, costly and largely preventable condition which affects over 300 million people worldwide and is recognised as the ‘third-leading’ cause of death in most countries. Adherence rates...

Read more

On demand webinar: The Price is Right? - Delivering UK access for niche patient populations

  With challenges to highly priced rare disease medicines and the Cancer Drug Fund evolving again – what is next, what are the ramifications for high priced/innovative treatments delivering beneficial outcomes...

Read more

Events

ON Helix

14th July 2015

ON Helix

ON Helix is our translational research conference for the life science sector. ON Helix is a one day event aimed at informing delegates of how to turn early stage inventions and...

Read more

CRISPR: Disruptive Technologies and Emerging Markets

18th August 2015

CRISPR: Disruptive Technologies and Emerging Markets

Since the discovery that our genes hold the keys to our health, the race has been on to find a precise method to edit our genomes. CRISPR provides the...

Read more

PharmaAfrica Market Access Conference

24th September 2015 - 25th September 2015

PharmaAfrica Market Access Conference

PharmaAfrica Market Access Conference is a leading event that will bring together experts to discuss the current market and patient access landscape in Africa, how it will be impacted by...

Read more

6th Annual World Orphan Drug Congress 2015

12th November 2015 - 13th November 2015

6th Annual World Orphan Drug Congress 2015

The World Orphan Drug Congress will be going into its 6th year in November 2015. The Congress was one of the first events to bring together the full range of...

Read more

Press Releases

Arthur G. Cook (ZS Associates) publishes 2nd Edition with Gower

15th April 2015

Arthur G. Cook (ZS Associates) publishes 2nd Edition with Gower

  The eagerly awaited second edition of Arthur G. Cook's Forecasting for the Pharmaceutical Industry is now available from Gower.     Forecasting for the Pharmaceutical Industry is a definitive guide for forecasters as...

Read more

New Schoonveld book is now available!

10th December 2014

New Schoonveld book is now available!

It's here!   The eagerly awaited new editon of THE PRICE OF GLOBAL HEALTH  is now available.   Written by global drug pricing expert Ed Schoonveld, The Price of Global Health (second edition) is...

Read more